Keebeck Alpha, LP Lantheus Holdings, Inc. Transaction History

Keebeck Alpha, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$58.87 - $83.05 $268,977 - $379,455	-4,569 Reduced 56.86%	3,466 $278,000
Q1 2024 May 13, 2024	BUY	$51.07 - $68.26 $242,735 - $324,439	4,753 Added 144.82%	8,035 $500,000
Q4 2023 Feb 12, 2024	BUY	$55.6 - $77.89 $182,479 - $255,634	3,282 New	3,282 $203,000
Q2 2023 Jul 25, 2023	BUY	$82.41 - $99.65 $25,135 - $30,393	305 Added 9.06%	3,671 $308,000
Q1 2023 May 11, 2023	BUY	$47.76 - $82.86 $160,760 - $278,906	3,366 New	3,366 $277,000
Q4 2020 Feb 05, 2021	SELL	$10.75 - $14.91 $188,737 - $261,774	-17,557 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$11.98 - $16.34 $232,495 - $317,110	-19,407 Reduced 52.5%	17,557 $222,000
Q2 2020 Aug 06, 2020	BUY	$10.34 - $15.51 $140,013 - $210,020	13,541 Added 57.81%	36,964 $529,000
Q1 2020 May 06, 2020	BUY	$9.11 - $20.05 $114,275 - $251,507	12,544 Added 115.3%	23,423 $299,000
Q4 2019 Feb 12, 2020	BUY	$18.47 - $24.03 $200,935 - $261,422	10,879 New	10,879 $223,000

533

73.2M

598K

371K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.19B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.